Literature DB >> 24995089

Venous thromboembolism is a product in proliferation of cancer cells.

Le-Min Wang1, Qiang-Lin Duan1, Xiang-Hua Yi2, Yu Zeng2, Zhu Gong1, Fan Yang3.   

Abstract

The pathogenesis of venous thromboembolism (VTE) in patients with cancer is related to the destruction of small veins and the intravenous formation of filamentous mesh-like structure by fibrinogen. The filamentous mesh-like filter can block hematogenous metastasis of cancer cells and also can stagnate blood cells, leading to venous thrombosis. Cancer cells have characteristics of malignancy and fast proliferation, and ischemic necrosis frequently occurs, and small veins were invaded and damaged. The formation of filamentous mesh-like structure has defense function and also may cause the occurrence of VTE. VTE is a product of the proliferation process of malignant cells.

Entities:  

Keywords:  Venous thromboembolism; cancer; filter

Year:  2014        PMID: 24995089      PMCID: PMC4073750     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  8 in total

Review 1.  Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance.

Authors:  Lee-Yee Chong; Elisabetta Fenu; Gerard Stansby; Sarah Hodgkinson
Journal:  BMJ       Date:  2012-06-27

2.  Confusion of wide thrombolytic time window for acute pulmonary embolism: mass spectrographic analysis for thrombus proteins.

Authors:  Lemin Wang; Zhu Gong; Jinfa Jiang; Wenjun Xu; Qianglin Duan; Jiangning Liu; Chuan Qin
Journal:  Am J Respir Crit Care Med       Date:  2011-07-01       Impact factor: 21.405

3.  Unprovoked venous thromboembolism: assess for cancer.

Authors:  Roekshana Shaboodien; Gerard Stansby; Beverley J Hunt; Roshan Agarwal
Journal:  Lancet Oncol       Date:  2012-10       Impact factor: 41.316

Review 4.  Epidemiology, risk and outcomes of venous thromboembolism in cancer.

Authors:  A Falanga; L Russo
Journal:  Hamostaseologie       Date:  2011-10-05       Impact factor: 1.778

Review 5.  Pulmonary embolism and deep vein thrombosis.

Authors:  Samuel Z Goldhaber; Henri Bounameaux
Journal:  Lancet       Date:  2012-04-10       Impact factor: 79.321

6.  Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer.

Authors:  Alok A Khorana; Steven A Ahrendt; Charlotte K Ryan; Charles W Francis; Ralph H Hruban; Ying Chuan Hu; Galen Hostetter; Jennifer Harvey; Mark B Taubman
Journal:  Clin Cancer Res       Date:  2007-05-15       Impact factor: 12.531

7.  Venous thromboembolism in patients with active cancer.

Authors:  Ali Seddighzadeh; Ranjith Shetty; Samuel Z Goldhaber
Journal:  Thromb Haemost       Date:  2007-09       Impact factor: 5.249

8.  Cancer-associated thrombosis.

Authors:  A K Kakkar
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

  8 in total
  4 in total

1.  Increased expressions of integrin subunit β1, β2 and β3 in patients with cancer ------correlation analysis between risk factors of VTE and expression of core proteins.

Authors:  Yanli Song; Lemin Wang; Fan Yang; Guiyuan Li; Qianglin Duan; Zhu Gong
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Internal relationship between symptomatic venous thromboembolism and risk factors: up-regulation of integrin β1, β2 and β3 levels.

Authors:  Qianglin Duan; Lemin Wang; Fan Yang; Jue Li; Yanli Song; Zhu Gong; Guiyuan Li; Haoming Song; Xiaoyu Zhang; Zugang Shen; Anthony Dart
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

3.  Early diagnosis of venous thromboembolism as a clinical primary symptom of occult cancer: Core proteins of a venous thrombus.

Authors:  Siwan Wen; Qianglin Duan; Fan Yang; Guiyuan Li; Lemin Wang
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

Review 4.  The origin and onset of acute venous thrombus.

Authors:  Lemin Wang; Qianglin Duan; Fan Yang; Siwan Wen
Journal:  Int J Clin Exp Med       Date:  2015-11-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.